These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 15919663)
1. Transactivation-dependent and -independent regulation of p73 stability. Dulloo I; Sabapathy K J Biol Chem; 2005 Aug; 280(31):28203-14. PubMed ID: 15919663 [TBL] [Abstract][Full Text] [Related]
2. A link between p73 transcriptional activity and p73 degradation. Wu L; Zhu H; Nie L; Maki CG Oncogene; 2004 May; 23(22):4032-6. PubMed ID: 15021899 [TBL] [Abstract][Full Text] [Related]
3. Mdm2-mediated NEDD8 modification of TAp73 regulates its transactivation function. Watson IR; Blanch A; Lin DC; Ohh M; Irwin MS J Biol Chem; 2006 Nov; 281(45):34096-103. PubMed ID: 16980297 [TBL] [Abstract][Full Text] [Related]
4. The p73 tumor suppressor is targeted by Pirh2 RING finger E3 ubiquitin ligase for the proteasome-dependent degradation. Jung YS; Qian Y; Chen X J Biol Chem; 2011 Oct; 286(41):35388-35395. PubMed ID: 21852228 [TBL] [Abstract][Full Text] [Related]
5. Human delta Np73 regulates a dominant negative feedback loop for TAp73 and p53. Grob TJ; Novak U; Maisse C; Barcaroli D; Lüthi AU; Pirnia F; Hügli B; Graber HU; De Laurenzi V; Fey MF; Melino G; Tobler A Cell Death Differ; 2001 Dec; 8(12):1213-23. PubMed ID: 11753569 [TBL] [Abstract][Full Text] [Related]
6. Negative autoregulation of p73 and p53 by DeltaNp73 in regulating differentiation and survival of human neuroblastoma cells. Nakagawa T; Takahashi M; Ozaki T; Watanabe K; Hayashi S; Hosoda M; Todo S; Nakagawara A Cancer Lett; 2003 Jul; 197(1-2):105-9. PubMed ID: 12880968 [TBL] [Abstract][Full Text] [Related]
7. DeltaNp73, a dominant-negative inhibitor of wild-type p53 and TAp73, is up-regulated in human tumors. Zaika AI; Slade N; Erster SH; Sansome C; Joseph TW; Pearl M; Chalas E; Moll UM J Exp Med; 2002 Sep; 196(6):765-80. PubMed ID: 12235210 [TBL] [Abstract][Full Text] [Related]
8. HMGB1 and HMGB2 cell-specifically down-regulate the p53- and p73-dependent sequence-specific transactivation from the human Bax gene promoter. Stros M; Ozaki T; Bacikova A; Kageyama H; Nakagawara A J Biol Chem; 2002 Mar; 277(9):7157-64. PubMed ID: 11748232 [TBL] [Abstract][Full Text] [Related]
9. E1A activates transcription of p73 and Noxa to induce apoptosis. Flinterman M; Guelen L; Ezzati-Nik S; Killick R; Melino G; Tominaga K; Mymryk JS; Gäken J; Tavassoli M J Biol Chem; 2005 Feb; 280(7):5945-59. PubMed ID: 15572378 [TBL] [Abstract][Full Text] [Related]
10. p73 Induces apoptosis via PUMA transactivation and Bax mitochondrial translocation. Melino G; Bernassola F; Ranalli M; Yee K; Zong WX; Corazzari M; Knight RA; Green DR; Thompson C; Vousden KH J Biol Chem; 2004 Feb; 279(9):8076-83. PubMed ID: 14634023 [TBL] [Abstract][Full Text] [Related]
11. Differential response of p53 target genes to p73 overexpression in SH-SY5Y neuroblastoma cell line. Goldschneider D; Blanc E; Raguénez G; Barrois M; Legrand A; Le Roux G; Haddada H; Bénard J; Douc-Rasy S J Cell Sci; 2004 Jan; 117(Pt 2):293-301. PubMed ID: 14676279 [TBL] [Abstract][Full Text] [Related]
12. Spatiotemporal switch from DeltaNp73 to TAp73 isoforms during nephrogenesis: impact on differentiation gene expression. Saifudeen Z; Diavolitsis V; Stefkova J; Dipp S; Fan H; El-Dahr SS J Biol Chem; 2005 Jun; 280(24):23094-102. PubMed ID: 15805112 [TBL] [Abstract][Full Text] [Related]
13. Possible oncogenic potential of DeltaNp73: a newly identified isoform of human p73. Ishimoto O; Kawahara C; Enjo K; Obinata M; Nukiwa T; Ikawa S Cancer Res; 2002 Feb; 62(3):636-41. PubMed ID: 11830511 [TBL] [Abstract][Full Text] [Related]
14. TAp73beta and DNp73beta activate the expression of the pro-survival caspase-2S. Toh WH; Logette E; Corcos L; Sabapathy K Nucleic Acids Res; 2008 Aug; 36(13):4498-509. PubMed ID: 18611950 [TBL] [Abstract][Full Text] [Related]
15. Transactivation-deficient Delta TA-p73 inhibits p53 by direct competition for DNA binding: implications for tumorigenesis. Stiewe T; Theseling CC; Pützer BM J Biol Chem; 2002 Apr; 277(16):14177-85. PubMed ID: 11844800 [TBL] [Abstract][Full Text] [Related]
16. Interplay between TAp73 Protein and Selected Activator Protein-1 (AP-1) Family Members Promotes AP-1 Target Gene Activation and Cellular Growth. Subramanian D; Bunjobpol W; Sabapathy K J Biol Chem; 2015 Jul; 290(30):18636-49. PubMed ID: 26018080 [TBL] [Abstract][Full Text] [Related]
17. Functional inactivation of p73, a homolog of p53 tumor suppressor protein, by human papillomavirus E6 proteins. Park JS; Kim EJ; Lee JY; Sin HS; Namkoong SE; Um SJ Int J Cancer; 2001 Mar; 91(6):822-7. PubMed ID: 11275986 [TBL] [Abstract][Full Text] [Related]
18. A naturally occurring p73 mutation in a p73-p53 double-mutant lung cancer cell line encodes p73 alpha protein with a dominant-negative function. Huqun ; Endo Y; Xin H; Takahashi M; Nukiwa T; Hagiwara K Cancer Sci; 2003 Aug; 94(8):718-24. PubMed ID: 12901798 [TBL] [Abstract][Full Text] [Related]
19. p73 induces apoptosis by different mechanisms. Ramadan S; Terrinoni A; Catani MV; Sayan AE; Knight RA; Mueller M; Krammer PH; Melino G; Candi E Biochem Biophys Res Commun; 2005 Jun; 331(3):713-7. PubMed ID: 15865927 [TBL] [Abstract][Full Text] [Related]
20. Involvement of N-terminally truncated variants of p73, deltaTAp73, in head and neck squamous cell cancer: a comparison with p53 mutations. Faridoni-Laurens L; Tourpin S; Alsafadi S; Barrois M; Temam S; Janot F; Koscielny S; Bosq J; Bénard J; Ahomadegbe JC Cell Cycle; 2008 Jun; 7(11):1587-96. PubMed ID: 18469517 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]